Last update 09 May 2025

Adalimumab biosimilar(Innovent Biologics (Suzhou) Co. Ltd.)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
Adalimumab biosimilar, SULINNO, IBI-303
+ [1]
Target
Action
inhibitors
Mechanism
TNF-α inhibitors(Tumor necrosis factor α inhibitors)
Inactive Indication
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Crohn Disease
China
01 Jun 2022
Pediatric Crohn's Disease
China
01 Jun 2022
Ankylosing Spondylitis
China
02 Sep 2020
Polyarticular Juvenile Idiopathic Arthritis
China
02 Sep 2020
Psoriasis
China
02 Sep 2020
Rheumatoid Arthritis
China
02 Sep 2020
Uveitis
China
02 Sep 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPhase 3-22 Sep 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
438
aoalfhnhdk(tnjqnpzuqq) = kvzlpakdbe vgaosqczfu (nzmfmmvwmf )
Similar
01 Sep 2019
aoalfhnhdk(tnjqnpzuqq) = bowdhoyfih vgaosqczfu (nzmfmmvwmf )
Phase 3
438
Adalimumab 40 mg
pkalnjywyy(gszxrevlsx) = pgbqfaiziz xmcctblyjt (sfbwbfhrwk )
Positive
01 Mar 2014
Placebo
pkalnjywyy(gszxrevlsx) = dktsvxzslc xmcctblyjt (sfbwbfhrwk )
Phase 4
150
xesxzfkxxc = ybbcyumcgo fmwpxgtxje (xrcivcleyk, fzrapbcoks - vjkrwitjay)
-
11 Mar 2013
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free